JOHN HARVILLE: Open Payments
NPI 1558871715 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 19 payments from 7 companies in 2025. Trend: 2023 $719 · 2024 $305 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $133 |
| Novo Nordisk Inc | 3 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $25 |
| PFIZER INC. | 1 | $15 |
Products named: Wegovy, LifeVest, Repatha, FARXIGA, OPSYNVI, MITRACLIP, ELIQUIS.
Industry payments across NC — which companies pay providers there.
